Greco Domenico, Gambina Francesco, Maggio Filippo
Division of Diabetology, S. Biagio Hospital, Marsala (TP), Italy.
Acta Diabetol. 2009 Mar;46(1):23-6. doi: 10.1007/s00592-008-0053-8. Epub 2008 Aug 29.
Ophthalmoplegia, despite being a rare entity in diabetes mellitus, is associated with great anxiety for the patients and often appears to be a serious problem from a diagnostic and therapeutic point of view. There have been few studies primarily concerned with the relative frequencies and clinical characteristics of oculomotor neuropathies in diabetic subjects. Those published have emanated largely from neurological and/or ophthalmological referral centres rather than metabolic departments. Objective of this study was to determine the incidence, the clinical characteristics and risk factors for developing ophthalmoplegia among persons with diabetes mellitus. We have performed a retrospective study of all diabetic patients with ophthalmoplegia who were seen in the Metabolic Division at "S. Biagio" Hospital, Marsala, over the 10 year period from 1998 to 2007. A detailed history and blood laboratory profile were obtained for each patient. During the period of the survey a total of 6,765 diabetic subjects were hospitalised and ophthalmoplegia was identified in 27 patients (0.40%). Isolated III nerve palsies accounted for the majority of patients (59.3%), with VI nerve palsies (29.6%) occurring more frequently than multiple palsies (11.1%). These patients had a marked comorbidity and were found to have a poorly controlled diabetes. The patients with VI nerve palsies showed a tendency toward a higher coexistence of diabetic retinopathy and cardiovascular risk factors than those with III cranial nerve palsies. Ophthalmoplegia is a serious and not common problem among patients with diabetes mellitus; the oculomotor nerve was most frequently affected in our case-report. The fact that the coexistence of diabetic complications and cardiovascular risk factors was slightly higher in patients with VI nerve palsy is compatible with the hypothesis that this ischemic event might be more closely related to diabetes and metabolic syndrome in its pathogenesis.
眼肌麻痹在糖尿病中虽属罕见,但会给患者带来极大焦虑,且从诊断和治疗角度来看,往往似乎是个严重问题。关于糖尿病患者动眼神经病变的相对发生率和临床特征的主要研究较少。已发表的研究大多来自神经科和/或眼科转诊中心,而非代谢科。本研究的目的是确定糖尿病患者发生眼肌麻痹的发病率、临床特征和危险因素。我们对1998年至2007年这10年间在马尔萨拉“圣比亚焦”医院代谢科就诊的所有糖尿病性眼肌麻痹患者进行了回顾性研究。为每位患者获取了详细病史和血液实验室检查资料。在调查期间,共有6765名糖尿病患者住院,其中27名患者(0.40%)被确诊为眼肌麻痹。孤立性动眼神经麻痹患者占大多数(59.3%),外展神经麻痹患者(29.6%)比多发性麻痹患者(11.1%)更常见。这些患者合并症明显,且糖尿病控制不佳。与动眼神经麻痹患者相比,外展神经麻痹患者糖尿病视网膜病变和心血管危险因素共存的倾向更高。眼肌麻痹在糖尿病患者中是一个严重且不常见的问题;在我们的病例报告中,动眼神经最常受累。外展神经麻痹患者糖尿病并发症和心血管危险因素共存率略高这一事实,与这种缺血性事件在发病机制上可能与糖尿病和代谢综合征关系更密切的假设相符。